Autonomix Medical, Inc. Common Stock

NasdaqCM AMIX

Autonomix Medical, Inc. Common Stock EBIT for the Trailing 12 Months (TTM) ending September 30, 2024: USD -13.86 M

Autonomix Medical, Inc. Common Stock EBIT is USD -13.86 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -94.45% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Autonomix Medical, Inc. Common Stock EBIT for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -7.13 M.
Key data
Date EBIT EBITDA Net Income EPS (Diluted)
Market news
NasdaqCM: AMIX

Autonomix Medical, Inc. Common Stock

CEO Mr. Bradley Hauser
IPO Date Jan. 29, 2024
Location United States
Headquarters 21 Waterway Avenue
Employees 5
Sector Health Care
Industries
Medical Instruments Biotechnology Pharmaceuticals
Description

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

StockViz Staff

January 15, 2025

Any question? Send us an email